TPEX:6523

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

NT$3.4b

Last Updated

2021/06/12 11:31 UTC

Data Sources

Company Financials

Executive Summary

Dr. Wu Skincare Co., Ltd. develops and sells skincare products in Taiwan and internationally. More Details


Snowflake Analysis

Flawless balance sheet and undervalued.


Similar Companies

Share Price & News

How has Dr. Wu Skincare's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 6523 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 6523's weekly volatility (6%) has been stable over the past year.


Market Performance


7 Day Return

-4.2%

6523

0.8%

TW Personal Products

0.6%

TW Market


1 Year Return

16.7%

6523

0.5%

TW Personal Products

49.2%

TW Market

Return vs Industry: 6523 exceeded the TW Personal Products industry which returned 0.5% over the past year.

Return vs Market: 6523 underperformed the TW Market which returned 49.2% over the past year.


Shareholder returns

6523IndustryMarket
7 Day-4.2%0.8%0.6%
30 Day0.1%2.3%9.9%
90 Day-12.3%-3.8%6.0%
1 Year35.9%16.7%4.2%0.5%54.2%49.2%
3 Year-2.3%-27.7%-5.2%-12.8%71.5%51.8%
5 Year-58.1%-70.2%27.6%10.8%139.7%97.1%

Long-Term Price Volatility Vs. Market

How volatile is Dr. Wu Skincare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Dr. Wu Skincare undervalued compared to its fair value and its price relative to the market?

39.2%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 6523 (NT$79.3) is trading below our estimate of fair value (NT$122.92)

Significantly Below Fair Value: 6523 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 6523 is good value based on its PE Ratio (5.1x) compared to the TW Personal Products industry average (15.5x).

PE vs Market: 6523 is good value based on its PE Ratio (5.1x) compared to the TW market (17.3x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 6523's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 6523 is good value based on its PB Ratio (1.9x) compared to the TW Personal Products industry average (2.2x).


Future Growth

How is Dr. Wu Skincare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

19.1%

Forecasted Household industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dr. Wu Skincare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Dr. Wu Skincare performed over the past 5 years?

9.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 6523 has a high level of non-cash earnings.

Growing Profit Margin: 6523's current net profit margins (84.9%) are higher than last year (20%).


Past Earnings Growth Analysis

Earnings Trend: 6523's earnings have grown by 9.2% per year over the past 5 years.

Accelerating Growth: 6523's earnings growth over the past year (270.7%) exceeds its 5-year average (9.2% per year).

Earnings vs Industry: 6523 earnings growth over the past year (270.7%) exceeded the Personal Products industry 4.7%.


Return on Equity

High ROE: 6523's Return on Equity (36.5%) is considered high.


Financial Health

How is Dr. Wu Skincare's financial position?


Financial Position Analysis

Short Term Liabilities: 6523's short term assets (NT$2.3B) exceed its short term liabilities (NT$479.3M).

Long Term Liabilities: 6523's short term assets (NT$2.3B) exceed its long term liabilities (NT$23.5M).


Debt to Equity History and Analysis

Debt Level: 6523 is debt free.

Reducing Debt: 6523 had no debt 5 years ago.

Debt Coverage: 6523 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 6523 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Dr. Wu Skincare current dividend yield, its reliability and sustainability?

5.35%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 6523's dividend (5.04%) is higher than the bottom 25% of dividend payers in the TW market (2.05%).

High Dividend: 6523's dividend (5.04%) is in the top 25% of dividend payers in the TW market (5.03%)


Stability and Growth of Payments

Stable Dividend: 6523 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 6523's dividend payments have increased, but the company has only paid a dividend for 5 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (25.9%), 6523's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.0yrs

Average board tenure


CEO

Yirui Wu

no data

Tenure


Board Members

Experienced Board: 6523's board of directors are considered experienced (6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Dr. Wu Skincare Co., Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Dr. Wu Skincare Co., Ltd.
  • Ticker: 6523
  • Exchange: TPEX
  • Founded: 2003
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: NT$3.370b
  • Shares outstanding: 45.05m
  • Website: https://www.drwu.com

Location

  • Dr. Wu Skincare Co., Ltd.
  • No.70, Nanjing East Road
  • 13th Floor
  • Taipei
  • 104
  • Taiwan

Listings


Biography

Dr. Wu Skincare Co., Ltd. develops and sells skincare products in Taiwan and internationally. The company offers cleansers, masks, toners, serums, moisturizers, and sunscreen and eye care products, as well...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/12 11:31
End of Day Share Price2021/06/11 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.